P/E at 59.45 vs Industry's 66.24: What the Data Shows for Apollo Hospitals Enterprise Ltd.

Valuation Picture: Discount Amidst Sector Premiums

The hospital sector currently commands a relatively elevated average P/E of 66.24, reflecting investor optimism about growth prospects and sector resilience. Against this backdrop, Apollo Hospitals Enterprise Ltd. trades at a P/E of 59.45, signalling a valuation discount of roughly 10.3%. This discount may indicate market caution or a more conservative outlook on the company’s near-term earnings growth relative to peers. However, it also suggests that the stock is not fully priced for the sector’s premium, potentially offering a more attractive entry point for investors sensitive to valuation metrics. Apollo Hospitals Enterprise Ltd.’s market capitalisation stands at ₹1,24,517.51 crores, firmly placing it in the large-cap category within the hospital sector.

Performance Across Timeframes: Mixed Momentum Signals

Examining returns over various periods reveals a divergence in momentum. Over the past year, Apollo Hospitals Enterprise Ltd. has delivered a respectable 10.32% gain, outperforming the Sensex which declined by 5.33% during the same period. Year-to-date, the stock has surged 22.97%, contrasting sharply with the Sensex’s 9.32% loss. This strong medium-term performance is further underscored by the three-year and five-year returns of 78.22% and 81.50% respectively, both significantly ahead of the Sensex’s 19.10% and 38.14% gains.

However, shorter-term trends are less encouraging. The stock has declined 1.79% over the past week and 1.64% over the last month, underperforming the Sensex’s modest gains of 0.06% and 1.61% respectively. Even the one-day performance shows a 0.46% drop compared to the Sensex’s 0.11% fall. This recent softness suggests some profit-taking or sector rotation pressures. The 3-month return of 3.04% still outpaces the Sensex’s 1.04%, but the narrowing gap raises questions about the sustainability of momentum — is this a temporary pause or a sign of shifting investor sentiment?

Moving Average Configuration: Signs of a Mixed Technical Landscape

The technical setup for Apollo Hospitals Enterprise Ltd. reveals a nuanced picture. The stock currently trades above its 100-day and 200-day moving averages, indicating that the longer-term trend remains intact and supportive. However, it is positioned below the 5-day, 20-day, and 50-day moving averages, signalling short-term weakness or consolidation. This configuration often suggests a recent pullback within a broader uptrend, where short-term momentum has faltered but the longer-term trend has not been decisively broken. The 5-day and 20-day averages are typically more sensitive to immediate price action, so the stock’s position below these levels may reflect recent profit-taking or sector-specific headwinds — is this a genuine recovery or a dead-cat bounce? — the moving average configuration provides the clearest answer.

Sector Performance Context: Hospital Industry Trends

The hospital sector has experienced mixed results recently, with some companies reporting robust earnings growth while others face margin pressures due to rising costs and regulatory challenges. The sector’s elevated average P/E of 66.24 reflects investor confidence in long-term growth drivers such as increasing healthcare demand and expanding insurance penetration. Within this environment, Apollo Hospitals Enterprise Ltd.’s valuation discount and mixed short-term performance may be symptomatic of sector rotation or company-specific factors. Sector results have been varied, with a number of stocks posting positive returns, some remaining flat, and others showing declines, underscoring the importance of stock-specific analysis in this space.

Rating Reassessment: Previously Strong Buy

On 20 Aug 2026, the rating for Apollo Hospitals Enterprise Ltd. was updated from Strong Buy to a new assessment. The previous Mojo Score was 77.0, reflecting a favourable view based on fundamentals and technicals. This reassessment aligns with the observed valuation discount and recent performance trends, suggesting a more cautious stance. The rating update invites investors to reconsider their positions — should investors in Apollo Hospitals hold, buy more, or reconsider?

Conclusion: A Complex Valuation and Performance Profile

The data for Apollo Hospitals Enterprise Ltd. reveals a stock trading at a meaningful discount to its hospital sector peers on a P/E basis, despite a strong medium- to long-term performance record. The one-year and year-to-date returns significantly outperform the Sensex, yet recent short-term weakness and a mixed moving average configuration suggest caution. The rating reassessment from Strong Buy to a new status reflects this nuanced picture, balancing valuation, momentum, and sector dynamics. Investors may find value in the stock’s relative discount but should weigh this against the recent technical signals — what is the current rating?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →